AIRS 8-K SEC Filing Analysis

Latest settled — T+20d ⚠ clustered

AIRS ▲ +32.38% at T+20d

NEUTRAL call ✓ call won +32.38% · α vs SPY +32.36% · entry $3.86 → $5.11

Next anchor: T+60d in 8w

Currently $5.28 · +36.79% from $3.86 entry

Entry anchored
May 7, 03:59 PM ET
via Databento tick

T+1d

+12.69%

call +12.69% · α +12.46%

$4.35

settled 4w ago

T+5d

+22.80%

call +22.80% · α +21.33%

$4.74

settled 26d ago

T+20d

+32.38%

call +32.38% · α +32.36%

$5.11

settled yesterday

T+60d

—

call — · α —

—

in 8w

Price Chart

Loading chart...

Executive Summary

AirSculpt Technologies reported Q1 2026 revenue of $39.4M (flat YoY) and a GAAP net loss of -$0.03 per share, in line with the consensus estimate of -$0.02. Same-center sales increased 1%, but adjusted EBITDA declined to $3.3M from $3.8M a year ago. The company reaffirmed its full-year 2026 guidance of $151M-$157M revenue and $15M-$17M adjusted EBITDA, signaling stabilization but no acceleration.

Key Financial Metrics

Guidance

$151M-$157M

maintained

Actionable Insight

The flat revenue and reaffirmed guidance suggest a stabilization narrative, but the lack of growth and declining adjusted EBITDA margin limit upside. Watch for Q2 seasonal strength and any change in case volume trajectory as a catalyst. The ATM offering overhang is partially offset by debt paydown.

Key Facts

Q1 2026 revenue flat at $39.4M vs $39.4M YoY
GAAP EPS -$0.03 vs consensus -$0.02 (in-line)
Same-center sales increased 1% YoY
Adjusted EBITDA declined to $3.3M from $3.8M YoY (margin 8.4% vs 9.5%)
Full-year 2026 guidance reaffirmed: revenue $151M-$157M, adjusted EBITDA $15M-$17M
Cash position improved to $16.7M from $8.4M at year-end; gross debt $45.6M
Raised $14.6M via ATM offering in Q1, paid down $11.4M of debt

Financial Impact

Revenue flat at $39.4M; net loss improved to -$2.4M from -$2.8M; adjusted EBITDA fell $0.5M to $3.3M

revenueepsadjusted EBITDAcash flow

Risk Factors

Continued case volume stagnation or decline
Adjusted EBITDA margin compression from higher SG&A costs
Potential dilution from ongoing ATM equity issuance
Competition from GLP-1 weight loss drugs impacting demand for body contouring

Market Snapshot

Exchange

Nasdaq

Sector

Services-Offices & Clinics of Doctors of Medicine

Analyst Consensus

0% bullish (7 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001870940-26-000026
Document: airs-20260508.htm	0001870940-26-000026
Document: 0001870940-26-000026-index-headers.html	0001870940-26-000026
Document: 0001870940-26-000026-index.html	0001870940-26-000026
Document: 0001870940-26-000026.txt	0001870940-26-000026
8-K Data (Synthetic)	0001870940-26-000026

8 reports for AIRS

T+1T+5T+20T+60

80% Hit rate 4 of 5 directional calls best @ T+5▲ +16.72%Apr 2, 2026

Filters

Reports for AIRS — sortable, filterable
	Type				Now
May 8, 2026 4w ago	8-K NEUTRAL ★ 4/10	$3.86 $5.11	▲ +32.38%	▲ +32.36%	$5.28 (+36.79%)
May 8, 2026 4w ago	Press Release BEARISH ★ 6/10	$3.86 $5.11	▼ −32.38%	▼ −32.36%	$5.28 (−36.79%)
May 1, 2026 5w ago	Press Release NEUTRAL ★ 2/10	$3.32 $5.30	▲ +59.64%	▲ +54.35%	$5.28 (+59.04%)
Apr 6, 2026 9w ago	10-K/A BEARISH ★ 7/10	$3.10 $3.44	▼ −10.97%	▼ −1.98%	$5.28 (−70.32%)
Apr 6, 2026 9w ago	Press Release BEARISH ★ 7/10	$3.10 $3.44	▼ −10.97%	▼ −1.98%	$5.28 (−70.32%)
Apr 2, 2026 9w ago	8-K BEARISH ★ 7/10	$3.17 $2.68	▲ +15.46%	▲ +25.33%	$5.28 (−66.56%)
Apr 2, 2026 9w ago	Press Release BEARISH ★ 7/10	$3.17 $2.68	▲ +15.46%	▲ +25.33%	$5.28 (−66.56%)
Mar 16, 2026 12w ago	Press Release MIXED ★ 6/10	$2.81 $2.62	▼ −6.60%	▼ −10.38%	$5.28 (+88.24%)

US Market Status

Market Closed — Opens Thu (10h 59m)

Related Tickers

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access